Management of Atrial Fibrillation With Flecainide : the AFFLEC Study

N/ACompletedNCT02190175

Hellenic Cardiovascular Research Society100 enrolled

Overview

This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.

the study objectives are * record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation * study of flecainide in ST interval

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Atrial Fibrillation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with history of atrial fibrillation * patients able to give informed consent Exclusion Criteria: * patients with coronary disease or other cardiopathy with left heart champer affected

Locations (3)

Erythros Stavros Hospital

Athens, Greece

University Hospital of Larisa

Larissa, Greece

AHEPA University Hospital

Thessaloniki, Greece

Outcomes

Primary Outcomes

ST interval and repolarization measures of myocardia in patients under treatment of flecainide

Time frame: 6months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.